CCL17-CCR4 Signalling Attenuates Pressure Overload-Induced Cardiac Remodelling Through IGFBP6 Suppression in Cardiac Fibroblasts
Background and Aims Chemokines regulate immune-cell trafficking, inflammation, and tissue repair in cardiovascular disease. C-C motif chemokine ligand 17 (CCL17) has been linked to adverse remodelling after myocardial infarction and neurohumoral stress, but its role during sustained mechanical pressure overload remains unclear. We investigated whether CCL17 regulates ventricular remodelling through signalling in cardiac fibroblasts. Methods We performed serum proteomic screening and assessed CCL17 in human serum and myocardial samples. We evaluated CCL17 function in mice subjected to transverse aortic constriction using global Ccl17 deletion and adeno-associated virus-mediated CCL17 augmentation. We used cardiac transcriptomics and pharmacological, small interfering RNA, and promoter-reporter experiments in cardiac fibroblasts to investigate downstream signalling. We tested the functional contribution of Igfbp6 in vivo using fibroblast-directed silencing. Results Serum CCL17 concentrations and myocardial CCL17 abundance were higher in patients with aortic stenosis than in controls. Cardiac and circulating CCL17 increased rapidly after transverse aortic constriction. Ccl17 deletion aggravated systolic dysfunction, hypertrophy, and fibrosis after pressure overload, whereas CCL17 augmentation attenuated these changes. Cardiac transcriptomics identified insulin-like growth factor-binding protein 6 (IGFBP6) as a candidate downstream mediator. In cardiac fibroblasts, CCL17 reduced cellular and secreted IGFBP6 levels and alpha-smooth muscle actin expression through C-C chemokine receptor 4 (CCR4)-dependent signalling, accompanied by suppression of early growth response 1 (EGR1). Genetic perturbation and promoter-reporter experiments supported a role for EGR1 in the regulation of Igfbp6 downstream of CCR4. Fibroblast-directed Igfbp6 silencing improved systolic function and reduced hypertrophy and fibrosis in Ccl17-deficient mice after transverse aortic constriction. Conclusions CCL17 attenuates maladaptive cardiac remodelling in mice subjected to pressure overload. The findings support a mechanism in which CCL17 acts through CCR4 and EGR1 to suppress IGFBP6 in cardiac fibroblasts. Keywords: Aortic stenosis, CCL17, cardiac fibrosis, fibroblasts, IGFBP6, pressure overload
Authors
- Wei Guo (ORCID: https://orcid.org/0000-0002-1923-6975)
- Zhipeng Lian (ORCID: https://orcid.org/0009-0002-6608-6276)
- Xin Wang (ORCID: https://orcid.org/0000-0002-6229-1945)
- Gaocheng Gu
- Pingjing Zheng
- Yuxiang Dai (ORCID: https://orcid.org/0000-0002-6144-9456)
- Wendi Yan
- ChunKa Wong
- Yang Zhang
- Xin Chen
Institutions
- University of Shanghai for Science and Technology (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.11.26367804
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- preprint